This site is intended for healthcare professionals

New integrated data and follow-up outcomes From Two Tepezza pivotal trials published in The Lancet Diabetes & Endocrinology.- Horizon Therapeutics

Read time: 3 mins
Last updated:17th Apr 2021
Published:17th Apr 2021
Condition: Thyroid Eye Disease
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest